A significant response to a combination of trastuzumab and vinorelbine in HER2-negative metastatic breast cancer with HER2 V777L mutation

A significant response to a combination of trastuzumab and vinorelbine in HER2-negative metastatic breast cancer with HER2 V777L mutation

Lei Lei,1,2,* Wei-Wu Ye,2,* Lin-Feng Zheng,3 Ping Huang,2 Lei Shi,2 Jian Huang,2 Ya-Bing Zheng,2 Zhan-Hong Chen,2 Xiao-Jia Wang,2 Xian Wang1 1Department of Medical Oncology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, China; 2Department of Medical...

Full description

Bibliographic Details
Main Authors: Lei L, Ye W, Zheng L, Huang P, Shi L, Huang J, Zheng Y, Chen Z, Wang X
Format: Article
Language:English
Published: Dove Medical Press 2019-04-01
Series:OncoTargets and Therapy
Subjects:
metastatic breast cancer
HER2 gene mutation
trastuzumab
Online Access:https://www.dovepress.com/a-significant-response-to-a-combination-of-trastuzumab-and-vinorelbine-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/a-significant-response-to-a-combination-of-trastuzumab-and-vinorelbine-peer-reviewed-article-OTT

Similar Items